301089 拓新藥業
按盤價 
26.920 -0.270 (-0.993%)
26.920 -0.270 (-0.993%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -0.710 | -4.588 | -1.260 | 16.316 | 23.166 |
| 總資產報酬率 ROA (%) | -0.634 | -4.070 | -1.106 | 13.202 | 17.704 |
| 投入資產回報率 ROIC (%) | -0.689 | -4.457 | -1.222 | 15.150 | 20.536 | 邊際利潤分析 |
| 銷售毛利率 (%) | 24.353 | 26.377 | 29.867 | 57.876 | 60.114 |
| 營業利潤率 (%) | -14.516 | -18.966 | -5.624 | 38.502 | 41.963 |
| 息稅前利潤/營業總收入 (%) | -14.020 | -19.113 | -7.388 | 37.483 | 41.080 |
| 淨利潤/營業總收入 (%) | -11.362 | -18.412 | -4.715 | 29.093 | 36.514 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 82.378 | 77.962 | 82.829 | 100.573 | 97.553 |
| 價值變動淨收益/利潤總額(%) | -5.618 | -5.895 | -5.600 | 2.248 | 1.775 |
| 營業外收支淨額/利潤總額(%) | 0.240 | 0.868 | 14.475 | -1.627 | -1.236 | 償債能力分析 |
| 流動比率 (X) | 4.107 | 4.007 | 4.095 | 4.227 | 2.392 |
| 速動比率 (X) | 2.718 | 2.763 | 3.013 | 3.177 | 1.823 |
| 資產負債率 (%) | 10.665 | 10.876 | 11.701 | 12.818 | 25.329 |
| 帶息債務/全部投入資本 (%) | 0.677 | 0.662 | 0.208 | 0.753 | 8.550 |
| 股東權益/帶息債務 (%) | 14,338.125 | 14,658.027 | 46,823.941 | 12,857.691 | 1,037.226 |
| 股東權益/負債合計 (%) | 837.666 | 819.445 | 754.662 | 680.152 | 294.798 |
| 利息保障倍數 (X) | -26.394 | -975.405 | 9.108 | -93.138 | -110.789 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 50.619 | 65.264 | 98.289 | 41.735 | 22.814 |
| 存貨周轉天數 (天) | 243.025 | 232.955 | 233.101 | 227.715 | 234.763 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 15/05/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
